Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) price on Thursday, July 03, fall -0.65% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $16.79.
A look at the stock’s price movement, the close in the last trading session was $16.9, moving within a range at $16.71 and $17.18. The beta value (5-Year monthly) was 0.953. Turning to its 52-week performance, $30.41 and $9.57 were the 52-week high and 52-week low respectively. Overall, ARWR moved 1.08% over the past month.
Arrowhead Pharmaceuticals Inc’s market cap currently stands at around $2.32 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-May-12.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ARWR is a 50% Buy. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
9 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 3 analyst(s) rate the stock as a Hold, 6 recommend ARWR as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ARWR’s current price about 4.12% and 9.81% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 60.12, while 7-day volatility ratio is 5.35% and 4.56% in the 30-day chart. Further, Arrowhead Pharmaceuticals Inc (ARWR) has a beta value of 0.95. Analysts have given the company’s stock an average 52-week price target of $30.485, forecast between a low of $24 and high of $52. Looking at the price targets, the low is -42.94% off current price level while to achieve the yearly target high, price needs to move -209.71%. Nonetheless, investors will most likely welcome a -81.57% jump to $30.485 which is the analysts’ median price.
If we refocus on Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR), historical trading data shows that trading volumes averaged 1.56 over the past 10 days and 1.83 million over the past 3 months. The company’s latest data on shares outstanding shows there are 138.06 million shares.
The 16.58% of Arrowhead Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 74.55% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 12.68 million on 2025-06-13, giving us a short ratio of 6.95. The data shows that as of 2025-06-13 short interest in Arrowhead Pharmaceuticals Inc (ARWR) stood at 1185.0 of shares outstanding, with shares short falling to 13.24 million registered in 2025-05-15. Current price change has pushed the stock -35.55% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ARWR stock continues to rise going into the next quarter.
